Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Infectious Diseases
Published in: BMC Infectious Diseases 1/2020

01-12-2020 | Tuberculosis | Research article

Tuberculosis active case-finding interventions and approaches for prisoners in sub-Saharan Africa: a systematic scoping review

Authors: Desmond Kuupiel, Portia Vezi, Vitalis Bawontuo, Ernest Osei, Tivani P. Mashamba-Thompson

Published in: BMC Infectious Diseases | Issue 1/2020

Login to get access

Abstract

Background

In sub-Saharan Africa (SSA), most prisons are overcrowded with poor ventilation and put prisoners disproportionally at risk of exposure to Mycobacterium tuberculosis (TB) and developing TB infection but are mostly missed due to poor access to healthcare. Active case-finding (ACF) of TB in prisons facilitates early diagnosis and treatment of inmates and prevent the spread. We explored literature and described evidence on TB ACF interventions and approaches for prisoners in SSA prisons.

Methods

Guided by the Arksey and O’Malley framework, we searched PubMed, Google Scholar, SCOPUS, Academic search complete, CINAHL and MEDLINE with full text via EBSCOhost for articles on prisoners and ACF from 2000 to May 2019 with no language restriction. Two investigators independently screened the articles at the abstract and full-text stages in parallel guided by the eligibility criteria as well as performed the methodological quality appraisal of the included studies using the latest mixed-method appraisal tool. We extracted all relevant data, organized them into themes and sub-themes, and presented a narrative summary of the results.

Results

Of the 391 eligible articles found, 31 met the inclusion criteria. All 31 articles were published between 2006 and 2019 with the highest six (19.4%) in 2015. We found evidence in 11 countries. That is, Burkina Faso, Cameroon, Coˆte d’Ivoire, the Democratic Republic of the Congo, Ethiopia, Ghana, Malawi, Nigeria, South Africa, Uganda, and Zambia with most 41.9% (13/31) recorded in Ethiopia. These intervention studies were conducted in 134 prisons between 2001 and 2018 using either a single or combination of mass, facility-led, entry, peer educators for routine screening, and exit ACF approaches. The majority (74%) of the studies utilized only a mass screening approach. The most (68%) reported study outcome was smear-positive TB cases only (68%). We found no evidence in 16 SSA countries although they are classified among the three high-burden country lists for TB TB/HIV and Multidrug resistant-TB group.

Conclusion

Our review highlights a dearth of evidence on TB ACF interventions in most SSA countries prisons. Hence, there is the need to scaling-up ACF interventions in SSA prisons, particularly countries included in the three high-burden country lists for TB, TB/HIV, and MDR-TB.
Appendix
Available only for authorised users
Literature
1.
Datiko DG. Peer education in prisons to improve tuberculosis case finding. Lancet Glob Health. 2019;7(4):e396–e7.PubMedCrossRef
2.
Gupta RK, Lipman M, Story A, Hayward A, de Vries G, van Hest R, et al. Active case finding and treatment adherence in risk groups in the tuberculosis pre-elimination era. Int J Tuberc Lung Dis. 2018;22(5):479–87.PubMedCrossRef
3.
Dodd PJ, Yuen CM, Sismanidis C, Seddon JA, Jenkins HE. The global burden of tuberculosis mortality in children: a mathematical modelling study. Lancet Glob Health. 2017;5(9):e898–906.PubMedPubMedCentralCrossRef
4.
World Health Organization. Global tuberculosis report 2018. Geneva, Switzerland: World Health Organization; 2018. Geneva, Switzerland: WHO/CDS/TB/2018.20. Available from: http://​apps.​ who. int/iris/bitstream … ; 2018.
5.
6.
Dheda K, Gumbo T, Maartens G, Dooley KE, McNerney R, Murray M, et al. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. Lancet Respir Med. 2017;5(4):291–360.CrossRef
7.
Al-Darraji HA, Altice FL, Kamarulzaman A. Undiagnosed pulmonary tuberculosis among prisoners in Malaysia: an overlooked risk for tuberculosis in the community. Trop Med Int Health : TM IH. 2016;21(8):1049–58.PubMedCrossRef
8.
Organization WH. Implementing the end TB strategy: the essentials. Genena, Switzerland: World Health Organization; 2015. Report No.: 9241509937.
9.
Uplekar M, Weil D, Lonnroth K, Jaramillo E, Lienhardt C, Dias HM, et al. WHO's new end TB strategy. Lancet. 2015;385(9979):1799–801.PubMedCrossRef
10.
de Vries SG, Cremers AL, Heuvelings CC, Greve PF, Visser BJ, Belard S, et al. Barriers and facilitators to the uptake of tuberculosis diagnostic and treatment services by hard-to-reach populations in countries of low and medium tuberculosis incidence: a systematic review of qualitative literature. Lancet Infect Dis. 2017;17(5):e128–e43.PubMedCrossRef
11.
Fahy S, Rights-Based TB. Programs for Migrants and Prisoners Needed in North Korea. Health Hum Rights. 2016;18(1):109–14.PubMedPubMedCentral
12.
Joshua IA, Dangata YY, Audu O, Nmadu AG, Omole NV. Human rights and nigerian prisoners--are prisoners not humans? Med Law. 2014;33(4):11–20.PubMed
13.
14.
Lambert LA, Armstrong LR, Lobato MN, Ho C, France AM, Haddad MB. Tuberculosis in Jails and Prisons: United States, 2002–2013. Am J Public Health. 2016;106(12):2231–7.PubMedPubMedCentralCrossRef
15.
Moyo N, Tay EL, Denholm J. 'Know your epidemic': are prisons a potential barrier to tb elimination in an Australian context? Trop Med Infect Dis. 2018;3(3).
16.
Nyasulu P, Mogoere S, Umanah T, Setswe G. Determinants of Pulmonary Tuberculosis among Inmates at Mangaung Maximum Correctional Facility in Bloemfontein, South Africa. Tuberc Res Treat. 2015;2015:752709.PubMedPubMedCentral
17.
18.
19.
Dara M, Chadha SS, Vinkeles Melchers NV, van den Hombergh J, Gurbanova E, Al-Darraji H, et al. Time to act to prevent and control tuberculosis among inmates. Int J Tuberc Lung Dis. 2013;17(1):4–5.PubMedCrossRef
20.
21.
Miller AC, Golub JE, Cavalcante SC, Durovni B, Moulton LH, Fonseca Z, Arduini D, Chaisson RE, Soares EC. Controlled trial of active tuberculosis case finding in a Brazilian favela. Int J Tuberc Lung Dis. 2010;14(6):720–6.
22.
Gupta-Wright A, Corbett EL, van Oosterhout JJ, Wilson D, Grint D, Alufandika-Moyo M, et al. Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial. Lancet. 2018;392(10144):292–301.PubMedPubMedCentralCrossRef
23.
Bjerrum S, Kenu E, Lartey M, Newman MJ, Addo KK, Andersen AB, et al. Diagnostic accuracy of the rapid urine lipoarabinomannan test for pulmonary tuberculosis among HIV-infected adults in Ghana–findings from the DETECT HIV-TB study. BMC Infect Dis. 2015;15(1):407.PubMedPubMedCentralCrossRef
24.
Khan MA, Anil S, Ahmed M, Athar A, Ghafoor A, Brouwer M. Active Case Finding of Tuberculosis: Randomized Evaluation of Simple and Infotainment Chest Camps. Annals Of Global Health. 2016;82(5):813–8.PubMedCrossRef
25.
Kranzer K, Afnan-Holmes H, Tomlin K, Golub JE, Shapiro A, Schaap A, et al. The benefits to communities and individuals of screening for active tuberculosis disease: a systematic review [State of the art series. Case finding/screening. Number 2 in the series]. 2013;17(4):432–46.
26.
Kuznetsov VN, Grjibovski AM, Mariandyshev AO, Johansson E, Bjune GA. A comparison between passive and active case finding in TB control in the Arkhangelsk region. Int J Circumpolar Health. 2014;73:23515.PubMedCrossRef
27.
Institute JB. Joanna Briggs Institute reviewers’ manual: 2015 edition/supplement. Methodology for JBI Scoping Reviews Adelaide: The Joanna Briggs Institute. 2015.
28.
Kuupiel D, Bawontuo V, Mashamba-Thompson TP. Mapping evidence on tuberculosis active case finding policies, strategies, and interventions for tuberculosis key populations: a systematic scoping review protocol. Syst Rev. 2019;8(1):162.PubMedPubMedCentralCrossRef
29.
Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467–73.PubMedCrossRef
30.
Hong QN, Pluye P, Fàbregues S, Bartlett G, Boardman F, cargo M, et al. MIXED METHODS APPRAISAL TOOL (MMAT) VERSION 2018.
31.
32.
Abebe DS, Bjune G, Ameni G, Biffa D, Abebe F. Prevalence of pulmonary tuberculosis and associated risk factors in Eastern Ethiopian prisons. Int J Tuberc Lung Dis. 2011;15(5):668–73.PubMedCrossRef
33.
Adane K, Spigt M, Ferede S, Asmelash T, Abebe M, Dinant GJ. Half of Pulmonary Tuberculosis Cases Were Left Undiagnosed in Prisons of the Tigray Region of Ethiopia: Implications for Tuberculosis Control. PloS One. 2016;11(2):e0149453.PubMedPubMedCentralCrossRef
34.
Addis Z, Adem E, Alemu A, Birhan W, Mathewos B, Tachebele B, et al. Prevalence of smear positive pulmonary tuberculosis in Gondar prisoners, North West Ethiopia. Asian Pac J Trop Med. 2015;8(2):127–31.PubMedCrossRef
35.
Adesokan HK, Cadmus EO, Adeyemi WB, Lawal O, Ogunlade CO, Osman E, et al. Prevalence of previously undetected tuberculosis and underlying risk factors for transmission in a prison setting in Ibadan, south-western Nigeria. Afr J Med Med Sci. 2014;43(Suppl 1):45–50.PubMedPubMedCentral
36.
Agajie M, Disassa H, Birhanu M, Amentie M. Prevalence of Pulmonary Tuberculosis and Associated Factors in Prisons of BenishangulGumuz Region, Western Ethiopia. Prevalence. 2018;6(9).
37.
Ali S, Haileamlak A, Wieser A, Pritsch M, Heinrich N, Loscher T, et al. Prevalence of pulmonary tuberculosis among prison inmates in Ethiopia, a cross-sectional study. PloS One. 2015;10(12):e0144040.PubMedPubMedCentralCrossRef
38.
Banda HT, Gausi F, Harries AD, Salaniponi FM. Prevalence of smear-positive pulmonary tuberculosis among prisoners in Malawi: a national survey. Int J Tuberc Lung Dis. 2009;13(12):1557–9.PubMed
39.
Biadglegne F, Rodloff AC, Sack U. A first insight into high prevalence of undiagnosed smear-negative pulmonary tuberculosis in Northern Ethiopian prisons: implications for greater investment and quality control. PloS One. 2014;9(9):e106869.PubMedPubMedCentralCrossRef
40.
Diendere EA, Tieno H, Bognounou R, Ouedraogo DD, Simpore J, Ouedraogo-Traore R, et al. Prevalence and risk factors associated with infection by human immunodeficiency virus, hepatitis B virus, syphilis and bacillary pulmonary tuberculosis in prisons in Burkina Faso. Med Trop (Mars). 2011;71(5):464–7.
41.
Ekundayo EO, Onuka O, Mustapha G, Geoffrey M. Active Case Finding of Pulmonary Tuberculosis among Prison Inmates in Aba Federal Prison, Abia State, Nigeria. Adv Infect Dis. 2015;5(01):57.CrossRef
42.
Fuge TG, Ayanto SY. Prevalence of smear positive pulmonary tuberculosis and associated risk factors among prisoners in Hadiya Zone prison, Southern Ethiopia. BMC Res Notes. 2016;9:201.PubMedPubMedCentralCrossRef
43.
Gebrecherkos T, Gelaw B, Tessema B. Smear positive pulmonary tuberculosis and HIV co-infection in prison settings of North Gondar Zone, Northwest Ethiopia. BMC Public Health. 2016;16(1):1091.PubMedPubMedCentralCrossRef
44.
Gizachew Beza M, Hunegnaw E, Tiruneh M. Prevalence and Associated Factors of Tuberculosis in Prisons Settings of East Gojjam Zone, Northwest Ethiopia. Int J Bacteriol. 2017;2017:3826980.PubMedPubMedCentralCrossRef
45.
Habeenzu C, Mitarai S, Lubasi D, Mudenda V, Kantenga T, Mwansa J, et al. Tuberculosis and multidrug resistance in Zambian prisons, 2000–2001. Int J Tuberc Lung Dis. 2007;11(11):1216–20.PubMed
46.
Henostroza G, Topp SM, Hatwiinda S, Maggard KR, Phiri W, Harris JB, et al. The high burden of tuberculosis (TB) and human immunodeficiency virus (HIV) in a large Zambian prison: a public health alert. PloS One. 2013;8(8):e67338.PubMedPubMedCentralCrossRef
47.
Kalonji GM, De Connick G, Okenge Ngongo L, Kazumba Nsaka D, Kabengele T, Tshimungu Kandolo F, et al. Prevalence of tuberculosis and associated risk factors in the Central Prison of Mbuji-Mayi, Democratic Republic of Congo. Trop Med Health. 2016;44:30.PubMedPubMedCentralCrossRef
48.
Karamagi E, Sensalire S, Muhire M, Kisamba H, Byabagambi J, Rahimzai M, et al. Improving TB case notification in northern Uganda: evidence of a quality improvement-guided active case finding intervention. BMC Health Serv Res. 2018;18(1):954.PubMedPubMedCentralCrossRef
49.
Kayomo MK, Hasker E, Aloni M, Nkuku L, Kazadi M, Kabengele T, et al. Outbreak of Tuberculosis and Multidrug-Resistant Tuberculosis, Mbuji-Mayi Central Prison, Democratic Republic of the Congo. Emerg Infect Dis. 2018;24(11):2029–35.PubMedPubMedCentralCrossRef
50.
Kwabla M, Ameme D, Nortey P. Pulmonary tuberculosis and its risk factors among inmates of a Ghanaian prison. Int J Trop Dis Health Health. 2015;9(3):1–10.
51.
Maggard KR, Hatwiinda S, Harris JB, Phiri W, Kruuner A, Kaunda K, et al. Screening for tuberculosis and testing for human immunodeficiency virus in Zambian prisons. Bull World Health Organ. 2015;93(2):93–101.PubMedPubMedCentralCrossRef
52.
Merid Y, Woldeamanuel Y, Abebe M, Datiko DG, Hailu T, Habtamu G, et al. High utility of active tuberculosis case finding in an Ethiopian prison. Int J Tuberc Lung Dis. 2018;22(5):524–9.PubMedCrossRef
53.
Noeske J, Kuaban C, Amougou G, Piubello A, Pouillot R. Pulmonary tuberculosis in the Central Prison of Douala, Cameroon. East Afr Med J. 2006;83(1):25–30.PubMedCrossRef
54.
Owokuhaisa J, Thokerunga E, Bazira J. Prevalence of Pulmonary Tuberculosis among Prison Inmates at Mbarara Central Prison South Western Uganda. Adv Res. 2014;2(11):618–25.PubMedPubMedCentralCrossRef
55.
Seri B, Koffi A, Danel C, Ouassa T, Blehoue MA, Ouattara E, et al. Prevalence of pulmonary tuberculosis among prison inmates: A cross-sectional survey at the Correctional and Detention Facility of Abidjan, Cote d'Ivoire. PloS One. 2017;12(7):e0181995.PubMedPubMedCentralCrossRef
56.
Telisinghe L, Fielding KL, Malden JL, Hanifa Y, Churchyard GJ, Grant AD, et al. High tuberculosis prevalence in a South African prison: the need for routine tuberculosis screening. PloS One. 2014;9(1):e87262.PubMedPubMedCentralCrossRef
57.
Winsa BB, Mohammed AE. Investigation on pulmonary tuberculosis among Bedele Woreda prisoners, Southwest Ethiopia. Int J Biomed Sci Eng. 2015;3(6):69–73.CrossRef
58.
Zerdo Z, Medhin G, Worku A, Ameni G. Prevalence of pulmonary tuberculosis and associated risk factors in prisons of Gamo Goffa Zone, south Ethiopia: A cross-sectional study. Am J Health Res. 2014;2(5):291–7.CrossRef
59.
Zishiri V, Charalambous S, Shah MR, Chihota V, Page-Shipp L, Churchyard GJ, et al. Implementing a large-scale systematic tuberculosis screening program in correctional facilities in South Africa. Open Forum Infect Dis. 2015;2(1):ofu121.PubMedCrossRef
60.
Chigbu LN, Iroegbu CU. Incidence and spread of Mycobacterium tuberculosis-associated infection among Aba Federal prison inmates in Nigeria. J Health Popula Nutr. 2010;28(4):327–32.
61.
Harris JB, Siyambango M, Levitan EB, Maggard KR, Hatwiinda S, Foster EM, et al. Derivation of a tuberculosis screening rule for sub-Saharan African prisons. Int J Tuberc Lung Dis. 2014;18(7):774–80.PubMedCrossRef
62.
Adane K, Spigt M, Winkens B, Dinant GJ. Tuberculosis case detection by trained inmate peer educators in a resource-limited prison setting in Ethiopia: a cluster-randomised trial. Lancet Glob Health. 2019;7(4):e482–e91.PubMedCrossRef
63.
64.
Dara M, Acosta CD, Melchers NVSV, Al-Darraji HAA, Chorgoliani D, Reyes H, et al. Tuberculosis control in prisons: current situation and research gaps. Int J Infect Dis. 2015;32:111–7.PubMedCrossRef
65.
Tavoschi L, Vroling H, Madeddu G, Babudieri S, Monarca R, Vonk Noordegraaf-Schouten M, et al. Active Case Finding for Communicable Diseases in Prison Settings: Increasing Testing Coverage and Uptake Among the Prison Population in the European Union/European Economic Area. Epidemiol Rev. 2018;40(1):105–20.PubMedPubMedCentralCrossRef
66.
67.
Yanjindulam P, Oyuntsetseg P, Sarantsetseg B, Ganzaya S, Amgalan B, Narantuya J, et al. Reduction of tuberculosis burden among prisoners in Mongolia: review of case notification, 2001–2010. Int J Tuberc Lung Dis. 2012;16(3):327–9.PubMedCrossRef
68.
Metadata
Title
Tuberculosis active case-finding interventions and approaches for prisoners in sub-Saharan Africa: a systematic scoping review
Authors
Desmond Kuupiel
Portia Vezi
Vitalis Bawontuo
Ernest Osei
Tivani P. Mashamba-Thompson
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2020
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-020-05283-1

Other articles of this Issue 1/2020

BMC Infectious Diseases 1/2020 Go to the issue

Research article

Antiviral mechanism of carvacrol on HSV-2 infectivity through inhibition of RIP3-mediated programmed cell necrosis pathway and ubiquitin-proteasome system in BSC-1 cells

Research article

The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial

Research article

Predictors of infectious meningitis or encephalitis: the yield of cerebrospinal fluid in a cross-sectional study

Research article

Computational MHC-I epitope predictor identifies 95% of experimentally mapped HIV-1 clade A and D epitopes in a Ugandan cohort

Research article

Sepsis in cancer patients residing in Zimbabwe: spectrum of bacterial and fungal aetiologies and their antimicrobial susceptibility patterns

Research article

Factors associated with antibiotic prescribing for acute bronchitis at a university health center
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits